Search

Pharynx / Larynx Cancer

C041

HYPOPHARYNGEAL CANCER BEFORE AND DURING THE ORGAN PRESERVATION EPOCH: A THIRTY-YEAR EXPERIENCE

Pharynx / Larynx Cancer

Adam C Gaunt, Dr1, Stephanie L Koonce, Dr2, Rachel J Lawrence, Dr1, George Garas, Dr3, Patrick J Bradley, Mr1, David G Grant, Dr1

1Queens Medical Centre, Nottingham UK, 2Cleveland Clinic, Florida USA, 3Imperial College and St Mary's Hospital, London UK


C042

DIFFERENT CLINICOPATHOLOGICAL PROFILES OF HPV-POSITIVE VERSUS HPV-NEGATIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS, WITH THE COMPLICATING FACTOR OF SMOKING: THE USC EXPERIENCE

Pharynx / Larynx Cancer

Changxing Liu, MD, PhD, Uttam K Sinha, MD, Niels Kokot, MD

USC Tina and Rick Caruso Department of Otolaryngology-Head and Neck Surgery, Keck Medicine of USC, University of Southern California


C043

IMPACT OF SMOKING HISTORY ON LOCOREGIONAL RECURRENCE-FREE, DISTANT METASTASIS-FREE SURVIVAL AND OVERALL SURVIVAL IN HUMAN PAPILLOMAVIRUS (HPV)-ASSOCIATED OROPHARYNGEAL CANCER (OPC) TREATED WITH DEFINITIVE (CHEMO)RADIOTHERAPY

Pharynx / Larynx Cancer

Howard Liu1, Anne Bernard2, Elizabeth Brown1, Laura Tam1, Matthew Foote1, Rob Milne2, Margaret McGrath1, Reza Rahbari1, Bena Cartmill1, Ben Panizza1, Sandro Porceddu1

1Princess Alexandra Hospital, 2University of Queensland


C044

QUALITY OF LIFE AFTER SUPRACRICOID PARTIAL LARYNGECTOMY

Pharynx / Larynx Cancer

Marianne Y Nakai, MD, Marcelo B Menezes, PhD, Julia V Boas, Lucas Porto M Dias, Lucas R Tenorio, MD, Leandro Augusto B Silva, MD, Antonio J Goncalves, PhD

Irmandade da Santa Casa de Misericórdia de São Paulo


C045

HPV STATUS IS NOT ASSOCIATED WITH BETTER SURVIVAL RATES IN LOW-PREVALENCE HPV INFECTION GEOGRAFIC REGIONS

Pharynx / Larynx Cancer

Rafael De Cicco, MD1, Rosilene M Menezes, MD, PhD2, Ulisses R Nicolau, MD, PhD1, Clovis A Pinto, Md, PhD1, Luiza L Villa, PhD3, Luiz P Kowalski, MD, PhD1

1AC Camargo Cancer Center, 2Hospital do Servidor Publico Municipal, 3Instituto do Cancer do Estado de São Paulo


C046

PREOPERATIVE PREDICTORS OF DIFFICULT HYPOPHARYNGEAL EXPOSURE DURING TRANSORAL SURGERY

Pharynx / Larynx Cancer

Kazunori Fujiwara, MD, PhD, Takahiro Fukuhara, MD, PhD, Satoshi Koyama, MD, PhD, Ryohei Donishi, MD, Hiromi Takeuchi, MD, PhD

Tottori University


C047

FIRST LINE SURGICAL TREATMENT OF OROPHARYNGEAL CARCINOMA WITH TRANS-ORAL ROBOTIC SURGERY (TORS): REVIEW OF A SINGLE INSTITUTIONS OUTCOMES

Pharynx / Larynx Cancer

Julia A Crawford, MD, Brett Leavers, Dr, Richard M Gallagher

St Vincent's Hospital Sydney


C048

INITIALLY-POSITIVE MARGINS PREDICT WORSE SURVIVAL IN PRIMARY, BUT NOT SALVAGE, TOTAL LARYNGECTOMY

Pharynx / Larynx Cancer

Patrick Tassone, MD, Corey Savard, Michael Topf, MD, William Keane, MD, Adam Luginbuhl, MD, Joseph Curry, MD, David Cognetti, MD

Thomas Jefferson University


C049

THE EXTENT OF NECK DISSECTION AMONG PATIENTS WHO RECEIVE ADJUVANT RADIOTHERAPY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA AND ITS EFFECT ON DISEASE- SPECIFIC AND OVERALL SURVIVAL.

Pharynx / Larynx Cancer

Usama Aboelkheir, MD, Austin Iovoli, BS, Alexis Platek, BS, Mary Platek, PhD, Anurag Singh, MD, Vishal Gupta, MD, David Cohan, MD, Wesley Hicks, MD, Hassan Arshad, MD

Roswell Park Cancer Institute


C050

PREDICTORS OF SWALLOW FUNCTION AFTER TRANSORAL SURGERY FOR LOCALLY ADVANCED OROPHARYNGEAL CANCER

Pharynx / Larynx Cancer

Jennifer Gross, MD1, Melanie Townsend, MD1, Joseph Zenga, MD2, Ryan Jackson, MD1, Bruce Haughey, MD, FACS3, Jason Rich, MD1

1Washington University Department of Otolaryngology, 2Massachusetts Eye and Ear Infirmary, 3Florida ENT Surgical Specialists